<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment of episodes of <z:hpo ids='HP_0001945'>fever</z:hpo> and <z:hpo ids='HP_0001875'>neutropenia</z:hpo> in pediatric hematology-<z:hpo ids='HP_0002664'>oncology</z:hpo> patients includes hospitalization and administration of intravenous antibiotics until the patient is afebrile and no longer neutropenic </plain></SENT>
<SENT sid="1" pm="."><plain>The present analysis characterizes retrospectively febrile episodes in neutropenic pediatric hematology-<z:hpo ids='HP_0002664'>oncology</z:hpo> patients with regard to frequency of documented <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, organisms associated with these <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, efficacy of a standardized antibiotic regimen, and safety of early antibiotic discontinuation under defined conditions </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 149 pediatric febrile neutropenic episodes were identified during a 4-year period between 1990 and 1994 </plain></SENT>
<SENT sid="3" pm="."><plain>These occurred in 47 male and 19 female patients, of a mean age of 7.6 years (range 0.5-15) </plain></SENT>
<SENT sid="4" pm="."><plain>The most frequent diagnoses were <z:hpo ids='HP_0001909'>leukemia</z:hpo> (41% of patients), <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (21%), <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> (7%), soft tissue <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (5%), Ewing's <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (5%), and <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> (4%) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> was certain in 36% of febrile episodes, probable in 14%, and not determined in 50% </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with severe <z:hpo ids='HP_0001875'>neutropenia</z:hpo> (absolute neutrophil count &lt; 100) had a slightly, although not significantly higher incidence of documented and probable <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (57%) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> had documented <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in 40% of their febrile episodes, and the detection rate in the children with <z:hpo ids='HP_0001909'>leukemia</z:hpo> was 31% (P &lt; .20) Blood cultures were positive in 21 (14%) of 149 episodes </plain></SENT>
<SENT sid="8" pm="."><plain>Staphylococci (both coagulase-negative and coagulase-positive strains) and Pseudomonas were the organisms most frequently isolated (six episodes each) </plain></SENT>
<SENT sid="9" pm="."><plain>Mouth and throat (11), lungs (10), and skin (10) were the next most frequent sites of <z:e sem="disease" ids="C0016397" disease_type="Disease or Syndrome" abbrv="">localized infection</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Initial treatment consisted of <z:chebi fb="0" ids="8232">piperacillin</z:chebi> and <z:chebi fb="0" ids="2637">amikacin</z:chebi> or of <z:chebi fb="0" ids="28001">vancomycin</z:chebi> and <z:chebi fb="0" ids="2637">amikacin</z:chebi> when the source of <z:hpo ids='HP_0001945'>fever</z:hpo> was thought to be an infected central line catheter, with addition of <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> by the seventh day of treatment when <z:hpo ids='HP_0001945'>fever</z:hpo> with <z:hpo ids='HP_0001875'>neutropenia</z:hpo> persisted or upon clinical suspicion of underlying <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>There was a single fatality, of a patient with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Antibiotics were discontinued when initial blood cultures had no growth after at least 48 hours and no source of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was found, the blood count was improving, and if the patient became afebrile and clinically well </plain></SENT>
<SENT sid="13" pm="."><plain>No patient needed readmission during the fortnight that followed discontinuation of antimicrobial therapy </plain></SENT>
<SENT sid="14" pm="."><plain>Patients with negative blood cultures under defined conditions, as described above, could safely be discharged early, thus shortening the duration of intravenous antibiotic therapy and hospital stay </plain></SENT>
</text></document>